Promising Results for Dupilumab in Treatment of Moderate to Severe COPD With Type 2 Inflammation

New data on dupilumab demonstrate the drug’s potential usefulness in treating type 2 inflammation, a role central to respiratory diseases, including chronic obstructive pulmonary disease (COPD).

Related Keywords

Milan ,Lombardia ,Italy ,Suryap Bhatt , ,European Respiratory Society ,International Congress ,Critical Care ,Copd ,Dupilumab ,Others ,